Is Pfizer a Great Dividend Stock?
_0.png?locale=de){kind=logo}
There's a lot of excitement today surrounding Pfizer (NYSE: PFE) and the COVID-19 vaccine that it's working on with BioNTech. The vaccine is more than 90% effective in preventing COVID-19, and while that is a great accomplishment, there's much more to the company than just its vaccine. It has a strong business that's produced solid, consistent results over the years.
Today, I'll focus specifically on Pfizer's dividend -- whether it is a great one and if it is suitable for income investors. To be a great dividend, it should not only pay better than the average stock on the S&P 500 does, but it should also be sustainable and likely to grow over the years. Here's a look at how Pfizer's dividend stacks up against those criteria.
Image source: Getty Images.
Source Fool.com
